Effects of Hesperidin on Insulin Sensitivity

NCT01773486 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Not funded

Conditions

Obesity
Insulin Resistance

Interventions

DRUG: Hesperidin
DRUG: Placebo

Sponsor

University of Maryland, Baltimore